"Dinoprostone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa.
Descriptor ID |
D015232
|
MeSH Number(s) |
D10.251.355.255.550.250.200 D23.469.050.175.725.250.200
|
Concept/Terms |
Dinoprostone- Dinoprostone
- PGE2 alpha
- alpha, PGE2
- Prostaglandin E2alpha
- E2alpha, Prostaglandin
- Prostaglandin E2
- E2, Prostaglandin
- Prostaglandin E2 alpha
- E2 alpha, Prostaglandin
- alpha, Prostaglandin E2
- PGE2
- PGE2alpha
|
Below are MeSH descriptors whose meaning is more general than "Dinoprostone".
Below are MeSH descriptors whose meaning is more specific than "Dinoprostone".
This graph shows the total number of publications written about "Dinoprostone" by people in this website by year, and whether "Dinoprostone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 |
2005 | 1 | 0 | 1 |
2006 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2012 | 1 | 1 | 2 |
2014 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2017 | 4 | 6 | 10 |
2018 | 8 | 5 | 13 |
2019 | 1 | 2 | 3 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Dinoprostone" by people in Profiles.
-
Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS One. 2021; 16(8):e0255335.
-
Comparative Anti-Inflammatory Effects of Salix Cortex Extracts and Acetylsalicylic Acid in SARS-CoV-2 Peptide and LPS-Activated Human In Vitro Systems. Int J Mol Sci. 2021 Jun 23; 22(13).
-
Assessment of Galectin-1, Galectin-3, and Prostaglandin E2 Levels in Patients with COVID-19. Jpn J Infect Dis. 2021 Nov 22; 74(6):530-536.
-
Bioactive lipids in antiviral immunity. Science. 2021 Jan 15; 371(6526):237-238.
-
Why does COVID-19 pathology have several clinical forms? Bioessays. 2020 12; 42(12):e2000198.
-
Russelioside B; A pregnane glycoside for treatment of gastric ulcer via modulation of heat shock protein-70 and vascular endothelial growth factor. Steroids. 2021 01; 165:108759.
-
The relationship between inflammatory markers and spirometric parameters in ACOS, Asthma, and COPD. J Asthma. 2020 12; 57(12):1273-1279.
-
Regulation of YAP by Mammalian Target of Rapamycin Complex 1 in Endothelial Cells Controls Blood Pressure Through COX-2/mPGES-1/PGE2 Cascade. Hypertension. 2019 10; 74(4):936-946.
-
Prostaglandin E2-Mediated Impairment of Innate Immune Response to A(H1N1)pdm09 Infection in Diet-Induced Obese Mice Could Be Restored by Paracetamol. J Infect Dis. 2019 02 15; 219(5):795-807.
-
Competitive Immunoassays for the Detection of Small Molecules Using Single Molecule Arrays. J Am Chem Soc. 2018 12 26; 140(51):18132-18139.